SIGA Technologies Inc (SIGA) stock
SIGANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3063% below fair value
$2.73−0.12 (-4.21%)
Close on Nov 17, 2026Market cap $196.15MP/E –Yield 21.98%
SIGA Technologies r&d expenses
Research and development expenses are spending on new products and technology.
SIGA Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $20.43M, up 43.6% year over year. For fiscal 2025 it was $19.96M, up 62.1% from the year before. Over ten years it grew 4.3% a year on average. The highest annual figure on record is $22.66M in fiscal 2010.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.96M | +62.1% |
| FY2024 | Dec 31, 2024 | $12.31M | -25.1% |
| FY2023 | Dec 31, 2023 | $16.43M | -27.1% |
| FY2022 | Dec 31, 2022 | $22.53M | +126.6% |
| FY2021 | Dec 31, 2021 | $9.94M | -9.1% |
| FY2020 | Dec 31, 2020 | $10.94M | -17.8% |
| FY2019 | Dec 31, 2019 | $13.30M | +2.2% |
| FY2018 | Dec 31, 2018 | $13.02M | -22.0% |
| FY2017 | Dec 31, 2017 | $16.68M | -15.4% |
| FY2016 | Dec 31, 2016 | $19.71M | +50.1% |
| FY2015 | Dec 31, 2015 | $13.13M | +22.6% |
| FY2014 | Dec 31, 2014 | $10.71M | -22.3% |
| FY2013 | Dec 31, 2013 | $13.79M | -24.3% |
| FY2012 | Dec 31, 2012 | $18.21M | -0.8% |
| FY2011 | Dec 31, 2011 | $18.37M | -18.9% |
| FY2010 | Dec 31, 2010 | $22.66M | +30.0% |
| FY2009 | Dec 31, 2009 | $17.42M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.39M | -0.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.95M | +14.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.04M | +50.8% |
| Q3 FY2025 | Sep 30, 2025 | $7.05M | +133.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.40M | +52.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.46M | +13.4% |
| Q4 FY2024 | Dec 31, 2024 | $3.34M | +27.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.02M | -17.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.89M | -43.5% |
| Q1 FY2024 | Mar 31, 2024 | $3.05M | -39.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.62M | -59.1% |
| Q3 FY2023 | Sep 30, 2023 | $3.65M | -36.4% |
| Q2 FY2023 | Jun 30, 2023 | $5.12M | -25.2% |
| Q1 FY2023 | Mar 31, 2023 | $5.05M | +42.3% |
| Q4 FY2022 | Dec 31, 2022 | $6.41M | +199.3% |
| Q3 FY2022 | Sep 30, 2022 | $5.73M | +77.2% |
| Q2 FY2022 | Jun 30, 2022 | $6.84M | +202.1% |
| Q1 FY2022 | Mar 31, 2022 | $3.55M | +54.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.14M | -28.8% |
| Q3 FY2021 | Sep 30, 2021 | $3.24M | +56.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.26M | -16.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.30M | -26.9% |
| Q4 FY2020 | Dec 31, 2020 | $3.01M | -23.4% |
| Q3 FY2020 | Sep 30, 2020 | $2.07M | -38.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.71M | +32.9% |
| Q1 FY2020 | Mar 31, 2020 | $3.15M | -21.2% |
| Q4 FY2019 | Dec 31, 2019 | $3.92M | +32.0% |
| Q3 FY2019 | Sep 30, 2019 | $3.34M | -10.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.04M | -38.5% |
| Q1 FY2019 | Mar 31, 2019 | $4.00M | +32.9% |
| Q4 FY2018 | Dec 31, 2018 | $2.97M | +6.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.72M | +50.7% |
| Q2 FY2018 | Jun 30, 2018 | $3.31M | -34.6% |
| Q1 FY2018 | Mar 31, 2018 | $3.01M | -52.7% |
| Q4 FY2017 | Dec 31, 2017 | $2.78M | -65.9% |
| Q3 FY2017 | Sep 30, 2017 | $2.47M | -59.3% |
| Q2 FY2017 | Jun 30, 2017 | $5.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.16M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.07M | – |
See a number that looks wrong?